Dr. Laetsch and his team hope to use that genetic information to guide the use of new, individualized treatments for children. Although the program is still in its infancy, exciting examples already show the potential power of such targeted molecular therapy. “By leveraging the clinical facilities at Children’s Health and UT Southwestern’s world-renowned research capabilities, we are perfectly positioned to identify new ways to deliver better cancer-fighting therapies to individual children,” said Dr. Stephen Skapek, Professor of Pediatrics and the Simmons Cancer Center, Chief of the Division of Pediatric Hematology and Oncology, and holder of the Distinguished Chair in Pediatric Oncology Research. “Generous philanthropic supporters like The Kids Shouldn’t Have Cancer Foundation are helping to accelerate this promising and transformational work.” Dr. Skapek is also the medical director of the Pauline Allen Gill Center for Cancer and Blood Disorders at Children’s Health. “We are thrilled to donate to the Precision Medicine Program and take one step further toward finding a cure for pediatric cancer,” said founder Kimberly Wade. “This contribution is significant because it is aimed at finding a cure for the disease that took my sweet son, Jonny, from us. His selfless wish that no other child should have cancer was the inspiration for the foundation, and I feel that we are honoring him directly by helping to fund a program that is keenly focused on improving the treatment process for children with this terrible disease.” The Kids Shouldn’t Have Cancer Foundation has made incredible efforts to fulfill Jonny’s wish in a short time. The foundation has raised over $500,000 for pediatric cancer research in the two years the foundation has been in existence.